The 10 most admired pharma companies in 2018

™

1

www.insightssuccess.in March 2018

T H E

MOST ADMIRED

PHARMA COMPANIES

2018

COMPANY OF THE MONTH

Pharmaceutical Marketing Social Media Marketing for Pharmaceutical Industry

Trends in Pharma Industry Revolutionary Factors Affecting Pharmaceutical Industry

Dilip Surana Chairman & MD Micro Labs Limited

Dr. Vishal Rajgarhia Director

FINECURE Pharmaceuticals Limited

Revitalizing Life with Good Health – “Making Lives Healthier”

Editorial

R

ight after the civilizations, the world changed for humans as it was attacked by various diseases. In this modern world with changed lifestyle, we are more prone to diseases and infections. Immunity level has diminished and as a result it is imperative to receive treatments accordingly.

With developments in science and research, mankind has discovered drugs for several diseases and effective treatment is possible now. Even the diseases that were said to be incurable have found the pharmacotherapeutics today. It is notable that, India once known for its medicinal knowledge in Ayurveda has excelled in the production of synthetic drugs in present days.

Indian Pharma Industry Leading a Global Change

Numerous companies from India have made their mark globally.

Currently, the pharmaceutical industry is undergoing a tremendous amount of change. The global pharmaceutical market is estimated to reach USD 1.43 trillion by 2020 and we can say without a doubt that the Pharma industry is responsible for the economic development of a nation. That is the main reason to propel for both research and development of newer and better products for various kinds of diseases.

The Indian Pharma industry is one of the most sought after and flourished industries. It is expected to grow over 15 per cent per annum between 2015 and 2020, and will outperform the global pharma industry, which is set to grow at an annual rate of 5 per cent in the same period. Going forward, better growth in domestic sales would also depend on the ability of companies to align their product portfolio towards chronic therapies for diseases such as cardiovascular, antidiabetes, anti-depressants and anti-cancers that are on the rise. High burden of disease, good economic growth leading to higher disposable incomes, improvements in healthcare infrastructure and improved healthcare financing are driving growth in the domestic market.

Pharma companies will continue to grow both organically and inorganically through alliances and partnerships. They will continue to focus on improving operational efficiency and productivity.

Developments in the health insurance, medical technology and mobile telephony can help the growth of the pharma industry by removing financial and physical barriers to healthcare access in India.

Nikita Doiphode

™

Editor-in-Chief Pooja M. Bansal Senior Editor Shraddha Deshpande Managing Editor Nikita Doiphode Co-Editors Shweta Priyadarshini Poulami Das Contributors Upama, Crescent Art & Design Director Amol Kamble Co-designer Savita Pandav Picture Editor Alex Noel Art Editor Shweta Ambilwade Visualiser Sapana Shinde Business Development Manager Akansha Garewal Marketing Manager Dhruv Apte Business Development Executives Priyanka, Ashwini, Meera Research Analyst David Circulation Manager Vivek Database Management Prashant Chevale Technology Consultant Swapnil Patil sales@insightssuccess.com

March, 2018 Corporate Ofces: Insights Success Media and Technology Pvt. Ltd. Off. No. 513 & 510, 5th Flr., Rainbow Plaza, Shivar Chowk, Pimple Saudagar, Pune, Maharashtra 411017 Phone - India: 020- 7410079881/ 82/ 83/ 84/ 85 Email: info@insightssuccess.in For Subscription: www.insightssuccess.in

Insights Success Media Tech LLC 555 Metro Place North, Suite 100, Dublin, OH 43017, United States Phone - (614)-602-1754 Email: info@insightssuccess.com For Subscription: www.insightssuccess.com

Cover Price : RS. 150/Follow us on :

www.facebook.com/insightssuccess/

https://twitter.com/insightssuccess

We are also available on : Copyright © 2018 Insights Success, All rights reserved. The content and images used in this magazine should not be reproduced or transmitted in any form or by any means, electronic, mechanical, photocopying, recording or otherwise, without prior permission from Insights Success.

Reprint rights remain solely with Insights Success. Printed and Published by Insights Success Media and Technology Pvt. Ltd.

CoverStory

CON 20

TECH HEALTH

Computer Technology Transforming Healthcare

32

CXO STANDPOINT Health Care Marketing

38

8

FINECURE Pharmaceuticals Limited Revitalizing Life with Good Health – “Making Lives Healthier”

Expert’s Advice

The Much Needed Industry, Home Healthcare Industry

TENTS 28

14

Company Of the month

Micro Labs:Delivering Value through High Quality Products

26

ASHISH LIFE SCIENCE

Providing Distinctive Animal Health Products Across the World

Interview with Insights Success

Abbott India Limited: Serving People in their Pursuit of Healthy Lives

42

GLOBAL CALCIUM

Making Everyday Life Better

Articles 34 Trends in Pharma 40 Future Of Pharma 22 Pharmaceutical Marketing Industry Technologies that will Impact the Pharmaceutical Companies in the Near Future

Social Media Marketing for Pharmaceutical Industry

Revolutionary Factors Affecting Pharmaceutical Industry

10ADMIRED T H E

MOST

PHARMA companies in 2018

Indian Pharmaceutical Industry: Reimagining Health

S

uccess in today’s pharmaceutical marketplace requires companies to continually reassess strategic direction, anticipate and absorb change, and move with deliberate speed. Leaders must step back, ask tough questions, and manage through ever-evolving obstacles to capture opportunity.

We are introducing some of the most prominent organizations in the industry who are capable of leading their clients towards excellence by supporting them beyond the advisory level. “The 10 Most Admired Pharma Companies in 2018” issue aspires to assist organizations to find the right pharmaceutical partner who has the resources and skills to deliver smart solutions with scalability and inventiveness.

The Cover Story features Finecure Pharmaceuticals Limited, a leading manufacturer and marketer of Pharmaceutical formulations, is benefiting the medical community and human health around the globe by addressing unmet medical needs.

We have encompassed, Micro Labs Limited as a Company of the Month which is a multi-faceted healthcare organization, dedicated to manufacturing medicine of the highest standard and marketing it at affordable prices across the Globe.

Apart from this, we have presented Ashish Life Sciences, a veterinary pharmaceutical company engaged in the wellness, prevention and treatment of diseases across a broad range of therapeutic areas for animals. Global Calcium, one of the most innovative companies providing pharmaceuticals, nutritional, veterinary and cosmetic products. Aastrid Life Sciences Pvt. Ltd. is a research base manufacturer of Intermediates, Fine & Specialty Chemicals for the Pharmaceutical and Allied industries. Apex Laboratories is a pioneer in the introduction of Zinc based formulations in India and continues to be the brand leader in the Multivitamin Mineral Supplements segment. Meyer Organics strives to respond sensitively to consumer needs, researching and developing scientifically proven healthcare solutions of a quality and efficacy suitable for world healthcare markets. Pharm easy is one of the largest pharmacy aggregators in India. They help patients connect with local pharmacy stores and diagnostic centers in order to fulfill their extensive medical needs. Ratnamani Healthcare Pvt. Ltd. is one of the youngest and most emerging pharmaceutical players in the export market. Avesthagen is a leading life science company pioneering the convergence between Food, Pharma and Population Genetics leading to predictive preventive personalized healthcare and food security.

Additionally, we have interviewed Venu Ambati, Managing Director of Abbott India Limited, who gave some insightful answers highlighting the influences made by his company to take healthcare towards newfound heights.

Scripted by our in-house editors, we have also included some remarkable articles titled “Revolutionary factors affecting Pharmaceutical industry”, “Technologies that will impact the pharmaceutical companies in the near future” and “Social Media Marketing for Pharma Industry” So flip through our magazine and explore interesting insights into the world of Pharma Companies!

FINECURE Pharmaceuticals Limited Revitalizing Life with Good Health “Making Lives Healthier”

“

With the belief of conviction, Finecure is committed to introducing new products that creates a better today and an even better tomorrow

“

“

Innovation always is the core and driving force of the company

“

I

ndia plays a pivotal role in the global pharmaceuticals Industry by being one of the largest providers of generic drugs globally. Innovation and low costs of manufacturing are some of the clear advantages that India offers in the global space. The Pharma industry has grown exponentially over the last few years. It has increased the life span and fostered hope in people with hitherto incurable illnesses. Medical innovations may not have yet provided the elixir of immortality, but it has certainly improved lifestyles, making lives healthier and decreasing

the uneasiness and discomfort felt by the sick and ailing.

Furthermore, it has led to an increased belief and trust in the Indian pharmaceutical industry.

In a mission to meet the unmet medical needs of society as a whole, Finecure Pharmaceuticals Limited, a leading manufacturer and marketer of Pharmaceutical formulations, is adding exceptional value and worth to the medical community and benefitting human health around the globe by creating innovative medicines that address the healthcare requirements of today.

The Company manufactures medicine in several therapeutic segments in dosage forms including tablets, capsules, liquids and dry syrup. The company is focused on delivering pioneering, competitive, and path breaking healthcare solutions for targeted results, specially focusing on therapeutic areas of infective diseases, cardiac diseases, diabetic diseases, skin care and pain management, gastrointestinal, anti-allergic, anti-asthmatics, multi-vitamins and nutraceutical segments.

With the belief of conviction, Finecure is committed to introducing new products that create a better today and an even better tomorrow. Their business has consistently outperformed the market and has grown at a compound annual growth rate (CAGR) of 39.71%, from 2013-14 to 2015-16, as compared to the Indian pharmaceutical industry outlook of CAGR of 12-13 % over next 5 years, making it one of the fastest growing pharmaceutical companies in India.

10ADMIRED T H E

MOST

PHARMA companies in 2018

Finecure’s journey so far has been an enterprising one with their commitment to serve. With a track record of success and achievement since their launch, it has been one full of rewards and recognitions. Moreover, they are rated CRISIL MSE1 for ‘Highest Financial Strength’ and ‘Highest Operating Performance’.

father Late Shri H.M Rajgarhia. Working with imagination, insight and boldness, and valuing the input of every single employee of the company, promoters brought out the best in people and brought them together with a shared sense of purpose. This is one of the prime reasons of Finecure’s success story.

Finecure continues to develop through a determined process of ‘Evolution through Innovation’. Innovation has always been at the core of their work systems and the driving force of the company. The company is aiming at increasing focus and penetration in Pharmaceuticals and Nutraceuticals markets including niche therapeutic products in Cardiovascular, Diabetology, Neurology, Retroviral, Derma, Anti-Infective and OTC segments both in the domestic and international markets. Additionally, the company focuses on value and investment in strategies centered on developing targeted portfolios and in developing stronger abilities in late-stage drug development.

The current Director of Finecure Pharmaceuticals Limited, Dr. Vishal Rajgarhia, has made Finecure into a working model that is ethical, transparent and implementable. Under his expert guidance, and with the strong support of his brothers, Vikash Rajgarhia and Vivek Rajgarhia, Finecure has received several recognitions including the prestigious ASSOCHAM Pharma Company of Year, 2016.

A Perceptive Leader Mr. Vikash Rajgarhia, Mr. Vivek Rajgarhia and Mr. Vishal Rajgarhia are the promoters of the company and learned entrepreneurship, integrity and leadership skills from their

“The promoters are human-focused and always believe in the mantra that we must give back to society more than what we receive from it,” says Dr. Vishal. The reason why Finecure chose to enter the world of pharmaceuticals was because of the firm belief that the only way to serve the ailing humanity was to bring into their world, medicines that they could afford. “Making lives healthier” has been the heart and soul of Finecure and ‘giving back to society’ and making ‘qualitative yet affordable medicines’ has become their guiding principle.

Distinguishing Strategies and Services Finecure Pharmaceuticals Limited was founded in 2005 with a mission and vision of “Making lives Healthier” by providing quality medicines with innovation and technology. The Company is poised for vertical growth with modern facilities, skills, know-how and resources that are at par with the best in the country. The company has state-of-the-art manufacturing facilities and maintains all specific set of standards mandated by the Food and Drug Control Administration.

“We believe in ourselves and have always believed in setting our own standards and character,” asserts Dr. Vishal. Finecure leverages every global development on the supply and demand side of the business. They continuously study the competition and deliver better proposition, value and products so that the market is inclined to their products. Also, their people are trained to create market and to build Brand Equity.

The Company focuses on their core strengths of quality, strict adherence to good manufacturing practices and

“

Quality is the reflecting mirror of the company

affordability. All its customers have confidence in their products and the way they conduct their business.

Finecure’s customers, irrespective of where they are located, understand who they are and earning their loyalty and trust is the biggest strategy that they employ.

Finecure Pharmaceuticals have been recognized for CIMS Innovation in Process and Formulation development Award and for Innovation in Beta Lactams by GHP UK and they intend to expand on their core strength of manufacturing these products and further innovate to offer value added products.

The Company believes that value proposition is very important to have a happy customer. “The driving policy on which we work is that once a customer, always a customer,” adds Dr. Vishal. To achieve this successfully, Finecure works on improving the customers’ confidence and to ensure utmost satisfaction and experience, it makes them feel good about doing business with Finecure. Due to their customer centric strategy, customers are bonded as an extended part of the Finecure Family. The key elements of running a successful business for them is being committed to the business and having a strong marketing team.

Great Accomplishments Since inception, the superlative growth in Pharma products reflects the constant combined efforts put in by the company which has helped them earn global acclaim. The long experience, professionalism of the employees, earned loyalty from their customers and a strong adherence to excellence in quality allows them to offer a high-quality product and a high level of service.

“

After years of endeavor, a nationwide network with respected acknowledgements has been built where manufacturing products are being sold through Finecure’s team nationwide and exported to several countries. Finecure attributes its success to keeping themselves updated to current market trends and needs, to offer products as per the market dynamics and to study the scope and expand its presence across geographies. Their greatest accomplishment is Finecure’s wonderful team that together forms a formidable task force for growth.

Awards and Praises

An Expert’s Advice for Budding Entrepreneurs

Some accolades earned by Finecure include “International Arch of Europe Award – Germany” for Quality & Technology in Gold Category in the year of 2012, “ASSOCHAM India Business Excellence Award 2013”, “Asia’s Most Promising Brand” validated by Consumers & Industry, “Process Advisors and Evaluators” KPMG in India in the year of 2013-14, “IPE Fastest Growing Pharma Company Award 2015”, “Innovation in Process and Formulation development Award 2016” by CIMS, “Pharma Company of the Year 2016” by ASSOCHAM INDIA, “Brand Excellence Award 2016” by ABP News “Pharma Company of the Year” by CMO Asia in the year of 2017, “ Dream companies to work for 2017” by Times Ascent World HRD Congress , and “SME Company of the year” in 2018 by ET NOW –Making of Developed India.

Finecure’s vision is not only to ensure that their bottom lines show profits, but through their products they have contributed to make the world a healthier and a better place.

“The younger generation is very talented and fast and those dreaming of entrepreneurship in Pharmaceutical Industry have a great future in store for them. The industry is growing at a fast pace and India is becoming the Hub of sourcing Pharmaceuticals globally. So, all those planning entrepreneurship can enter into the pharma space and the industry has a lot to offer to all.”

Future Roadmap Finecure has been recognized for Quality management and Business Excellence due to the policies and team working with ethos. They are poised to offer the society innovative products which will add value to patient's life and also to the company’s goals.

Finecure aims to metamorphose into an integrated multifaceted product formulation powerhouse- a dynamic Pharma and Nutraceutical solutions provider to match the ever-changing market needs on par with the best in the world.

MICRO LABS LTD:

C

urrently, the Indian pharmaceuticals market is the third largest in terms of volume and the thirteenth largest in terms of value and is expected to grow to a whooping US$ 100 billion by 2025. Driven by increasing consumer spending, rapid urbanization, and raising healthcare insurance, India enjoys a significant position in the worldwide pharmaceuticals sector.

Micro Labs Limited, a multi-faceted healthcare organization, has contributed greatly in placing India amongst the top pharmaceutical markets of the world.

Micro Labs, aided with their proficient marketing team, state-of-the-art manufacturing facilities and top-notch R&D centers, is one of the fastest growing transnational healthcare organizations. Moreover, the company is backed by strong distribution network and path-breaking research which resulted in them being ranked 13th among Prescriptions according to SMSRC Jan 18' and 19th in Sales as per AWACS MAT Jan 18'.

A frontrunner in the pharmaceutical industry, Micro Labs is built around strong believes in quality, ethics, customer focus, and respect for people. Their vision is to be a leader in the development, manufacture, and sales of premium pharmaceutical products.

Dedicated to manufacturing medicine of the highest standard and marketing it at affordable prices across the globe, Micro Labs is poised to achieve unparalleled status in the global pharmaceutical industry. Their brand portfolio includes some of the topmost brands in various specialties like Cardiology, Diabetology, Anti-infectives, Ophthalmology, Pain, etc. Additionally, the company is involved at social and environmental fronts striving to be a model corporate citizen.

14 10

A True Entrepreneur Dilip Surana, the Chairman and Managing Director of Micro Labs, is the man behind the company’s unmatched success. With over 20 years of rich experience in pharmaceuticals, Dilip Surana currently holds the 73rd position among the 100 Richest Indians .

When he took over Micro Labs from the reigns of his father, Mr. G. C. Surana, hardly anyone could assume the stupendous success he would achieve. “My father’s ability to pick up the chemistry of a drug was amazing. For him there was no holiday. He lived and breathed business and inculcated the same values in me. Even during my high school days, he made sure I learn the trade, starting from the lowest rung,” says Dilip Surana.

The growth of Micro Labs has a lot to do with Mr. Dilip’s vision and passion. He consistently brings in fresh ideas and under his expert guidance, Micro Labs became one of the few companies in the mid-1980s to have separate strategic business units that focused on areas such as cardiology, neurology, dermatology and nephrology.

Due to his remarkable efforts in the success of Micro Labs, Mr. Dilip has been a regular participant in various international seminars and summits relating to pharma industry. He is instrumental in inducting Senior Pharma veterans in the company while bringing in the much needed professionalism in the company.

Under Dilip Surana’s leadership, the company is rightly regarded as a pioneer in many ways as it has introduced various molecules in India for the very first time. He has also established world class state-of-the-art research and manufacturing facilities covering Active Pharmaceutical March 2018|

™

Company of the Month

‘‘

We are dedicated in developing top of the line pharmaceutical products while adhering to

‘‘“

highest quality norms with the help of a well qualified

and renowned research team

Dilip Surana Chairman & MD

™

| March 2018 |

15 01

Today, with Dilip Surana’s efforts, the company is committed to carry out world-class research that develops bio-equivalent generics. However, in spite of all his success, this kindhearted and visionary chairman of Micro Labs has a simple living attitude.

“When you’re an entrepreneur, everything’s on the line.

People don’t realize that. You believe so much in it, you’re willing to risk everything, as I did. It’s hard to lose everything and start over again. But I think that’s what separates successful entrepreneurs from unsuccessful ones — the ability to fall off your bike, get back on and keep riding. It’s very hard to achieve success but it’s even harder to maintain success. Trying to expand and get bigger even are more challenging” says Mr.Dilip.

An Inspirational Voyage The story of Micro Labs cannot unfold without mentioning their inspirational founder and leader Mr. G. C. Surana.

With a humble beginning as a Pharmaceutical Distributor in Bangalore, Mr. Surana began a marketing and distributions agency for a pharmaceutical company. With his valuable experience and sheer dedication towards hard work, he founded Micro Labs Limited in 1973.

Mr. Surana’s perseverance and leadership has led Micro Labs from a modest pharmaceutical manufacturing company to its current success as a leading name in the pharmaceutical industry. Over the years, Micro Labs has reinforced its position as an industry leader and was proud to unveil their state-of-the-art ophthalmic plant, the first of its kind in Asia, in July 2006.

Today, Micro Labs is a multi-faceted organization with an annual turnover of Rs.2700 Crore, including exports that contribute Rs. 920 Crore. The distinguished attributes of the company are the 14 oral formulation plants including an injectable unit; a bulk drug facility, offices located overseas, and a strong distribution network. Their marketing efforts span into 20 divisions, with each division specialized to cater various therapeutic segments. The organization’s most important component, however, remains its 9200 dedicated employees.

With state-of-the-art facilities and 3 R&D centers designed to international standards, Micro Labs is poised to become a respected global brand in the pharmaceutical field and highlight our nation’s growing reputation in the Global scenario.

Outstanding Products and Services Micro Labs’ initiation into the pharmaceutical business began with a number of quality products in niche healthcare

10 16

“

“

Ingredients (APIs) and finished dosage forms as well as infrastructure for new drug discovery.

At Micro Labs, we have processes in place & our greatest strength are our people

areas like anti-bacterial compounds, antiseptics and vitamins. The company has since created a strong presence in the healthcare market owing to their stringent quality control and distribution standards combined with innovative products.

Under the expert leadership of Mr. Dilip, Micro Labs have evolved into a diversified pharmaceuticals manufacturing company with products ranging from oral solids, topicals to injectibles. The company has 14 plants that have been contributing significantly to the healthcare needs of the domestic market for over three decades. Micro Labs has a long term commitment to developing Bio-equivalent Generics with the help of world class research and high quality standards. Their main focus remains on developing new formulations in various dosage forms including solid dosage, liquid dosage, sterile preparations, injectables, creams, ointments, etc.

The continuous strive for perfection has led Micro Labs towards building state-of-the-art facilities which has assisted their growth in the regulated markets. The company’s vision to create a Vertically Integrated Organization that offers a wide range of products has led them to set up their very own API Manufacturing facilities.

Mr. Dilip has instilled the most stringent quality standards in his pharmaceutical enterprise. As a result, Micro Labs has to its credit, all the international regulatory approvals including US FDA, UK MHRA, MCC, South Africa, Health Canada, WHO, Geneva TGA, Australia Medsafe, New Zealand PAHO (USA), IDA (Netherlands) and many regulatory bodies of emerging markets reflecting the high standards of quality and regulatory compliance of research and manufacturing facilities.

Future Endeavors Micro Labs has been in a continuous stage of growth ever since the founding years and continues to chart its course as a leader in the pharmaceutical vertical. The company has presence in over 40 countries with ground level operations in over 15 countries, exporting all major dosages on most of the therapeutic segments.

They have started looking at in-licensing locally, whereas internationally they have more of a joint venture approach.

They are doing a lot of molecule-to-molecule as well as country-to-country business. As they aim to be associated with quality, their focus will be on niche generics and retroviral drugs. ™

| March 2018 |

Read it First

Subscribe today Yes I would like to subscribe to Insights Success Magazine.

Global Subscription 1 Year.......... (12 Issues) .... Rs. 2500

6 Months ..... (06 Issues) .... Rs. 1300

3 Months .... (03 Issues) ....

1 Month ...... (01 Issue) .....

Rs. 700

Rs. 250

Date :

Name : Address :

Telephone : Email :

City :

State :

Zip :

Country :

Cheque should be drawn in favour of : INSIGHTS SUCCESS MEDIA AND TECH PVT. LTD.

CORPORATE OFFICE â„¢

Insights Success Media and Technology Pvt. Ltd. Off No. 513 & 510, 5th Flr, Rainbow Plaza, Shivar Chowk, Pimple Saudagar, Pune, Maharashtra 411017.

Phone - India: 020- 7410079881/ 82/ 83/ 84/ 85 USA: 302-319-9947 Email: info@insightssuccess.in

10ADMIRED T H E

MOST

PHARMA companies in 2018 Company Name

Management

Brief

Aastrid Life Sciences aastridlifesciences.com

Ravindra V. Jagtap Director

Aastrid Life Sciences Pvt. Ltd., is a research base manufacturer of Intermediates, Fine & Speciality Chemicals for the Pharmaceutical and Allied industries.

Apex Laboratories Ltd apexlab.com

Murali Srinivasan Director

Apex Laboratories is a pioneer in the introduction of Zinc based formulations in India and continues to be the brand leader in the Multivitamin Mineral Supplements segment.

Ashish Life Sciences Pvt. Ltd. ashishlifescience.com

Raujesh Agarrwal Founder

Ashish Life Sciences is a veterinary pharmaceutical company engaged in the wellness, prevention and treatment of diseases across a broad range of therapeutic areas for animals.

Avesthagen avesthagen.com

Parag Shah CEO

Avesthagen is a leading life science company pioneering the convergence between Food, Pharma and Population Genetics leading to predictive preventive personalized healthcare and food security.

Finecure Pharmaceuticals finecurepharma.com

Vishal Rajgarhia Director

Finecure Pharmaceuticals Limited, a leading manufacturer and marketer of Pharmaceutical formulations, is benefiting the medical community and human health around the globe by addressing unmet medical needs.

Global Calcium Pvt. Ltd. globalcalcium.com

Sahil Vaz CEO

Global Calcium is one of the most innovative companies providing pharmaceuticals, nutritional, veterinary and cosmetic products.

Meyer Organics Pvt Ltd meyer.co.in

Uma Kalekar Director

Meyer Organics strives to respond sensitively to consumer needs, researching and developing scientifically proven healthcare solutions of a quality and efficacy suitable for world healthcare markets.

Microlabs Ltd microlabsltd.com

Dilip Surana Chairman & MD

Micro Labs Limited is a multi-faceted healthcare organization, dedicated to manufacturing medicine of the highest standard and marketing it at affordable prices across the Globe.

Pharm easy pharmeasy.in

Dharmil Sheth Founder & President

Pharm easy is one of the largest pharmacy aggregators in India.

They help patients connect with local pharmacy stores and diagnostic centres in order to fulfil their extensive medical needs.

Ratnamani Healthcare Pvt Ltd zettaset.com

Mr. Jeetu Sanghvi Director (Promoter)

Ratnamani Healthcare Pvt. Ltd. is one of the youngest and most emerging pharmaceutical player in the export market.

TECH HEALTH

Computer Technology Transforming Healthcare About the Author With more than 10 years of cumulative experience in surgical navigation system R&D, clinical and marketing & sales, Arpit Paliwal is the challenge loving Founder of HRS Navigation, who has done executive program in sales & marketing from IIM Calcutta.

He was managing the navigation business for all India as part of the Stryker (Fortune 500), where they were already developing the navigation system back in 2007. It was during his tenure that he came across various hospitals for computer assisted surgeries & realized the need for simple, affordable navigation solution.

Arpit has also been awarded with the Annual Product Performance Award for navigation and for bringing around the navigation business in India.

10 20

™

| March 2018 |

C

omputer Assisted Surgery aims to improve patient care by the utilization of computer based technologies during the procedure; to amplify the benefits; to encourage interdisciplinary collaboration between engineers and physicians in developing new concepts and applications. The scope of Computer Assisted Surgery encompasses all major fields within surgery, as well as biomedical imaging and instrumentation, and digital technology employed as a supplement to imaging in diagnosis, therapeutics, and surgery.

Surgical Precision Surgery is a distressing experience at best. Medical robotics and CAS (Computer Assisted Surgery) helps alleviate the problem. They have been used in a wide variety of fields from head and neck to urologic surgery. They provide greater reach and flexibility, smaller incisions made with more precision which is enough to access the targeted anatomy. This results in more accurate pre-operative planning, reduction of operating time, avoiding damage to healthy tissues, exact alignment of surgical instruments with anatomy and faster patient recovery. It’s an established fact about the benefit of these technologies & ever increasing uses support the fact.

Revolution In recent years there has been a definite shift to the use of minimally-invasive techniques, performed by steering surgical tools through small incisions in the patient’s skin in order to minimize blood loss and soft tissue damage, and consequently, reduce postoperative pain and recovery time.

There are CAS technologies which work on CT/MRI images of patient to guide in real time. These are used mostly in Brain, ENT & Spine surgeries. Some CAS technologies which uses ultrasound are being used in soft tissue biopsies for liver, lungs & breasts. Also there are technologies which are image-less. These are used in Knee, Hip implants surgeries.

These technologies made the complex surgeries safer & less pain full. Now for e.g. in brain surgeries surgeons can plan the surgery on computer generated 3D model of the patient by marking areas of interest & danger areas. During surgery system then guides the surgeon to reach area of interest & alerting the surgeon if he is operating near any danger region. It gives confidence to the surgeon on more aggressive on the tumor & still gentle to any critical part of ™

| March 2018 |

the brain following the shortest and safest path. Medical robots are also getting developed to perform various part of brain surgery to take the brain surgery to next dimension.

Similarly in the spine surgery the misplacement of spine screw is quite common. Misplaced screw can cause permanent damage to nervous system. With the help of CAS rate of misplacement has been significantly reduced make it safer for the patients. Various standard reviews have bespoken the superiority of CAS technique compared to others for pedicle screw placement. Accuracy rates of around 95% are commonly reported with CAS which is quite high when compared to free-hand techniques. Also it helps to reduce the harmful X-ray radiation dosage for operating team and the patient.

Robotic surgeries are growing at very rapid rate. Robots are performing surgeries which require dexterity which can't be achieved by human hand. They have tiny wristed instruments which can bend and rotate more than the human hands providing greater reach through smaller incision.

Augment Reality The recent emerging role and integration of virtual reality (VR) and augmented reality (AR) in healthcare is transforming this data rich field and justify consideration for future applications to enhance the surgical experience.

For e.g. a new technology which augments X-ray vision on the real patient anatomy to help surgeon plan and execute the operation effectively. It’s like a superman viewing through the skin of patient.

Growing Market The world-wide robotic surgery & CAS market is expected to reach USD 20.8 billion by 2024 as per a market research, report. The ubiquity of chronic disorders around the globe is on a rise. These diseases hence need surgery for the treatment solution. CAS & Robotic surgeries for these cases provides minimally invasive approach, fewer complications, faster recovery, lower pain and blood loss, thereby propelling the demand over the forecast period.

Computer assisted technologies are rising & becoming standard of care. Lot of innovations are happening. Future looks promising once these technologies reaches to masses & make everyone benefitted from them.

10 21

Future Of Pharma

Technologies that

will Impact the PHARMACEUTICAL

Companies in the

Near Future

F

or years, pharmaceutical industries are trying to keep pace with the rapid speed of technology. Pharmaceutical industries are still unclear about how the new digital technologies are going to impact drug development and commercialization. Several industrial experts feel that emerging technologies such as AI and 3D printing will bring changes to the business models, operations, workforce, and cyber security. Recently, a new plasmonic sensor was developed by researchers to detect early cancer forms.

Though, the healthcare sectors are slow in adapting to the innovation and technologies, they need to be more concerned and ensure that medications are safe to consume. So, here are the trends that are making an impact on the pharmaceutical industry in the near future.

3D Printed Drugs 3D printing starts with a computer-aided design of a digital model of the product. Think of a future, where taking a single tablet to cure the problem instead of taking numerous drugs several times a day while the patient is in multiple chronic conditions. By using 3D Printer, drugs can be produced in peculiar shapes, sizes and colors such as starďŹ sh, dinosaurs and many other interesting shapes in order to make the kids take pills happily and elder patients can easily swallow it. There is an issue in bringing pharmaceutical products to the market, due to strict regulatory requirement which are needed to adapt to the environment and accept printing as a method of manufacture. The ultimate goal is to make the drug creation process predictable, calculable, and thus safe from every regulatory point of view.

10 22

™

| March 2018 |

Digital Health “Around the Pill” For decades, pharmaceutical industries are trying to offer something beyond traditional pills and drugs to bring effective changes to the patients. Instead of producing drugs and developing pills, a leading research team has proposed to bring a change to the medicine's physical appearance itself. Also, one of the Pharmaceutical Companies from Japan is planning to involve a wearable monitoring device and an App, through which patients can receive positive feedback from their doctors and from the automated personalized feedback generated by the app itself.

Artificial Intelligence and Cognitive Computers With the leading technology of artificial intelligence and cognitive computers, doctors can identify the disease present in the patients within seconds, instead of going through lots of experiment and tests for hours or days. Artificial intelligence can help in gathering the information related to the disease from a vast database in seconds. So, once the disease is identified, the drugs are supplied to treat the patient in a shorter period of time. Due to artificial intelligence involvement, time consumption and lots of money is saved from experiments and also, the price of the medicine reduces in the marketplace.

Virtual Reality (VR) Nowadays, even the pharmacy industries are planning to invest on virtual reality to work against pain killers. Due to virtual reality, the patients suffering from stress, tension and pain are deflected elsewhere. As a patient with mental health problems, VR can help them fight possible fear of schizophrenia more successfully. Perhaps the pharma companies believe the future will be VR pharmacies with specialists prescribing the appropriate VR treatment to patients.

Nanotechnology For over years, nanotechnology is developing to bring an impact to healthcare and in the field of genetic engineering. A lot of professionals from Pharma Industry hope that Nanotechnology is going to unleash breakthroughs in genetic engineering, medicine, diagnosis and in various types of dosage forms in pharmacy. German institute researchers came closer to realizing the vision in developing Nano robots in the form of swallowing pills or can be inserted into the blood stream to perform surgery and hopefully cure the diseases like breast cancer and heart surgery from within the body.

The Future of pharmaceutical industries can bring a great change to the environment with technology innovation. Though, adapting to the new technology in the healthcare sectors is a challenging firm. Pharmaceutical industries can’t rely on trial-and-error approaches to deal with existential risk for longer period of time anymore. Today, the necessity is to increase our investment in developing defensive technology. Many changes can be brought to people by pharmaceutical industry unless it generates a passion to compassionate with the developing technologies.

™

| March 2018 |

10 23

10ADMIRED T H E

MOST

PHARMA companies in 2018

ASHISH LIFE SCIENCE: Providing Distinctive Animal Health Products Across the World

hroughout the ages, humans are dependent on animals for services, food, and companionship.

In modern times, animals have played a crucial role in research settings where diseases are studied and drug therapies are developed. Ashish Life Science was founded with a strong believe that animals have been catering to serve mankind and it is our duty to reciprocate it.

T

The Mastermind behind ALS Founder of Ashish Life Sciences, Raujesh Agarrwal, completed Master’s in Business Management and later joined the family Business, which was founded in 1975 by his father Premsukh Agarrwal. When he joined the Ashish Group of Industries, it mainly dealt with textiles, plastic products, chemicals, medical devices, bulk drugs, etc. and were also involved in trading and export of these products.

The founder of Ashish Life Science (ALS), Raujesh Agarrwal, realized the potential of Indian Veterinary medicine during his travel to different countries. He recognized the huge business prospective for Animal Health Products in International markets. As most European companies are leading the international markets, and all Indian Pharmaceuticals companies are focusing on Human Health products, he decided to start manufacturing and exporting veterinary products.

“Customers have been the sole reason for the existence of ALS as an organization and providing quality products at a reasonable price has always been the motto,” says Raujesh.

He constantly makes sure that they are always connected with the customers to understand their distress areas and resolve them effectively. At ALS, they help customer to grow their business. “Our customers rely on us and that trust encourages us to do much more for them,” shares Raujesh.

ALS, established in 2002, is a Veterinary pharmaceutical company engaged in the wellness, prevention and treatment of diseases across a broad range of therapeutic areas for animals. The company operates through innovative products and established veterinary businesses. It manufactures and exports Veterinary Pharmaceutical products to more than 50 countries across the Globe. “Our quality is beyond the horizon of any negotiation,” says Raujesh. Hence, a World Class Manufacturing Facility has been set up that meets the stringent CGMP guidelines of many regulatory bodies.

Raujesh makes sure that every employee understands the importance of customer satisfaction and together they can ensure customer delight. Satisfied customer base and dedicated team of people has made this possible.

At ALS, they are a team of dedicated professionals who believe in learning, empathy and innovation. They exhibit high diligence at every level and function. Adherence to quality, best-in-class manufacturing practices, investment in infrastructure development, highest levels of laboratory certification and high service standards have enabled them to build lasting relationships across the Globe.

Additionally, ALS is one of the first companies in India specializing in Veterinary Pharmaceuticals to receive the WHO-GMP certification. They are also recognized and approved by various overseas Health authorities and renowned Quality Assurance Experts from Europe. Also, their manufacturing facility is approved by various health authorities like Tanzania, Uganda, Kenya, Zimbabwe, Malawi, Nigeria, and Ethiopia for the supply of Veterinary Medicines.

Remarkable Offerings ALS is the first dedicated Indian veterinary products manufacturing company that has received WHO-GMP Certificates for their production plant. With exporting to more than 50 countries, ALS has become a brand in many countries. With a team of young and dedicated people, ALS aims to reach great heights.

26 10

They offer a range of cutting-edge veterinary products,

™

| March 2018 |

‘‘

‘‘

We believe in creating values in the human-animal ecosystem

world-class manufacturing infrastructure and relationship driven approach. At ALS, they are consistently evolving to meet their customers’ needs across the Globe. They strive to deliver significant value to their customers by understanding their needs and innovating to offer the right choice of products.

ALS operates across the entire spectrum of therapeutic segments – Antiparasitics, Ectoparasiticides, NSAIDs, Antibiotics, Antifungal, Antiprotozoal, Tonics, and Neutraceuticals to name a few. Besides, they also offer all dosage forms – bolus, tablets, powder, suspensions, solutions, oral paste, injectable and spray & ointments – ensuring that their clients also have an ease and effectiveness of administration. They have set up a state-ofthe-art liquid injection line with some unique attributes.

They have gathered the resources and skills required to achieve this task.

ALS provides cost-effective products and is aiming to get into the regulatory market as there is a huge scope for generics in the veterinary segments. The company has built its infrastructure and its F&D capabilities around this strategy. It has products that are volume builders but at the same time they are introducing innovative products to tap into the overlooked needs. ™

| March 2018 |

Raujesh Agarrwal Founder

Awards and Accolades Ashish Life Science has won the “SME Business Excellence Awards 2014”, Presented by D&B, The Times Group & Federal Bank. ALS has also been recognized as “India’s Small Giants” by India SME in 2014. Furthermore, Raujesh was interviewed by ET NOW after ALS was recognized as an emerging “Pharma Company in micro segment”.

Additionally ALS has won the prestigious “Top 100 SMEBOI Awards” (Achievers of 2012), the “Top 100 SMEBOI Awards” (Achievers of 2013) and the “ECGCD&B- India Exporters Excellence Awards 2015- Best Manufacturing Exporters” Award along with the Golden Maharashtra MSME’s “Manufacturing Summit 2015 Award.

ALS has also been features in the well-known Dollar Business magazine in 2016.

Future Aspects “There has been a clear vision to know what we want to achieve in future. We anticipate the future and gear up to adopt the future trends,” says Raujesh. To become & maintain leadership position, ALS aims to enter regulated markets like Europe, Australia, South Africa and the US.

27 01

Venu Ambati Managing Director, Abbott India Limited

28

™

| March 2018 |

Interview with Insights Success

ABBOTT INDIA LIMITED: Serving People in their Pursuit of Healthy Lives

I

ndia enjoys an important position in the global pharmaceuticals sector. The Indian pharmaceuticals market is the third largest in terms of volume and thirteen largest in terms of value. Since 1910, Abbott India Limited has been one of the top contributors to the Indian pharmaceuticals market. In an interview with Insights Success, Venu Ambati, Managing Director of Abbott India Limited gave some insightful answers highlighting the influences made by his company to take healthcare towards newfound heights.

1. Brief us about Abbott India Limited and what kinds of services, solutions or products are offered by Abbott at par with the current industry standards?

Headquartered in Mumbai, Abbott India Limited (AIL), is a publicly listed company and a subsidiary of Abbott, USA. At AIL, we offer high-quality trusted medicines across multiple therapeutic categories such as women’s health, gastroenterology, neurology, metabolic disorders, general care, vitamins, and vaccines. With an employee strength of more than 3000, we have a portfolio of over 110 brands for healthcare professionals that promote health and well-being for people across stages in life.

At AIL, we are all about helping you live the best life you can through good health. Whether it’s an ordinary headache or a more serious illness, we want people to get better fast, so they can go back to doing the things they love. In our pharmaceuticals business, we offer quality medicines for people in emerging markets. Our state-of-the-art manufacturing plant at Goa produces high volume and high quality formulations. We have over 15 brands in top position, and 3 brands in top 100, with a market-beating double-digit growth year-on-year.

We have an endless drive to bring meaningful innovation to our markets – in both medicines and the services that go along with them – to help people live healthier, fuller lives. We give people a reason to choose our medicines, and this model has led to consistent, exceptional growth.

2. Which is the biggest challenge you faced in the industry and how did you overcome it?

For an industry that works towards improving people’s health, accessibility is a major issue. At Abbott, we aim to reach out to as many people as we can through several access-improving programs, and through technology, by helping doctors and patients communicate better. Digital interventions and technology play a great role here. For example, more than 160,000 doctors worldwide use Knowledge Genie, Abbott’s multi-channel knowledge centre, to stay on top of important scientific developments in medicine. Knowledge Genie provides doctors access to news about the latest treatments and techniques from more than 3,000 medical journals and 2,000 ebooks, as well as daily updates on research and clinical developments. ™

| March 2018 |

10 29

3. What should be in the DNA of a growing team of Abbott India Limited? How will clients benefit from your expertise?

I am privileged to be leading a high performing team, committed to strengthening the legacy of Abbott and enhancing our promise to help millions of people live a healthier, happier and a more fulfilling life. We value the diversity in our team, because as part of our DNA, we believe that different perspectives combined with shared goals inspire new ideas and better ways of addressing changing health needs.

We focus on exceptional performance – a hallmark of Abbott people worldwide – demanding of ourselves and each other because our work impacts people’s lives. We strive to earn the trust of those we serve by committing to the highest standards of quality, excellence in personal relationships, and behaviour characterized by honesty, fairness and integrity.

We sustain success—for our business and the people we serve—by staying true to key tenets upon which our company was founded over a century ago: innovative care and a desire to make a meaningful difference in all that we do.

4. What would you attribute your success to and what are your greatest accomplishments?

I attribute my success to the people around me. I share my successes and challenges with my team. I lean on these people for support and encouragement.

And similarly, my achievement also lies in when I see the people around me become successful. The people I have worked with in my career – to groom them and then to see them grow and go places – it is an exhilarating feeling and is a great accomplishment for me!

5.Which innovations by you were highly acclaimed and accepted by the Industry?

We have given a major boost to the service + pills initiative in the industry. Our Lifestyle modification program for preventing conditions such as NAFLD (Non-Alcohol related Fatty Liver Disease) is one of the firsts in the industry where we are reaching out to patients and doctors through technology.

As the industry is shifting from treatment to prevention, such programs will ensure continued benefit to patients and their needs. Applying these incremental innovations to existing off-patent medicine provides added value to our patients. Whilst this approach is common in other industries such as consumer goods, this insight-driven approach is less common in pharma.

6. How do you build a successful customer base and achieve a long term relation with them? What are the key elements followed by you for a successful business?

Abbott is one of the top healthcare companies in India. For us, leadership is multi-faceted and goes much beyond commercial leadership. We believe that if we can create multiple patient-centric healthcare eco-systems in India that’s true leadership, because only then can we truly help people get healthy.

Abbott is in fact the only multinational company whose pharmaceutical business is 100 percent focused on emerging markets. We have built our business to be driven locally, yet powered globally. We believe in insight-driven innovation that differentiates our medicines.

Importantly, Abbott is seen as a trusted brand in the eyes of the doctors and patients – and that is due to our demonstration of quality and commitment over a period of time. I believe gaining trust takes time – but it only comes with consistent, credible and sustainable results.

I am also a strong advocate for reverse mentoring. I believe that core competencies required for great leadership do not necessarily come only with experience. The values of kindness, empathy, integrity, respect and courage are something that can be imprinted on all employees. While vertical hierarchy is strongly in place in India, gradually companies should and are formalizing the reverse mentoring process in order to ensure best practices in today’s digital world.

7. What is the best part of Abbott India Limited, and how are you going to utilize it in future projects?

As I mentioned before, though we are an MNC, we are driven locally. We have the spirit of entrepreneurship in our people. No idea is considered small. Such kind of incubation and pro-innovation attitude ensures that everyone is appreciated and pushed to do better in their own way.

Younger employees come with different learnings and belief systems, and their presence definitely adds pace and compassion to the workforce. They have smart ideas to reach rural stakeholders through IoT (Internet of things) & emerging technologies, and interesting ideas to solve complex problems like disease prevalence- using big-data.

We have a Think Tank set up in the organization that allows any employee to pitch ideas to the teams - these programs boost growth and enthusiasm, and ensure cross-functional collaboration. We have several projects that have been started as a part of Think Tank and going forward we intend to continue the push.

10 30

™

| March 2018 |

CXO Standpoint

HEALTHCARE

Marketing T

he online space has become the blood line for health information. The ascension of digital tools and technologies has a transient impact across daily life and business globally including healthcare too. The Godspeed growth in use of the net, mobile apps, and social media channel as well as the exponential uptake of personal use of computing, smart phones and tablets by all healthcare stakeholders – including, healthcare experts, patients and financers is well documented.

Considering the pace with which the volume of marketing has grown, its way difficult to measure of how much impact these phenomenon are having on the delivery and outputs of medical interventions, hence requires a strategic roadmap to track down the influence.

Inbound Marketing is the answer This new strata of marketing includesdeveloping marketing strategies, 360degree online advertisement, adwords, search engine optimization email marketing and social media marketing.

A high-level view of key business indicators facilitates faster and more

10 32

accurate feedbacks and review puts all of that at your fingertips.

Now day’s people are more info-savvy and in regards to the marketer needs to curate share-able content that has wide reach, sparking debate among healthcare communities, providers, payers, patients and manufacturers.

Moreover, it needs fully engaging content across communications channels to maximize message reach, with services like: public affairs, highlevel conclaves with key persons, multimedia portal, print and digital strategy/reports, campaigns, partnerships, and internal communications.

The Educated Patient No doubt that the role of social media in healthcare and its influence on patient engagement is taking the limelight, powered by mobile technology, patient demand and growing influence of the digital depended generation. How ready the healthcare sector is for these concerned and digitally demanding patients will be a subject of conversation and assessment.

Hospitals and other medical association are an important online stakeholder, with a more better resourced and commercial approach towards social media. For example, any Clinic Center for Social Media could be a leading portal and advocate of social media in healthcare with a presence on channels like YouTube, Facebook, Twitter, LinkedIn and numerous blogs sites. Investing in these channels the group is not only benefiting patients while growing its brand but also giving better understanding to its stakeholders about its all over capabilities. Patients of toady want to get engaged and be taken seriously when they approached. One grey area of patient dissatisfaction is a lack of any sort of acknowledgement when they share any sort of experience or their demands with a healthcare outfit. A well-managed social media presence not only gives a forum for patient engagement, but also enhances online-sourcing ideas and feedback to stimulate conversation around new tactics or changes within the organization.

Healthcare Marketing: More Important than Ever Digital marketing, a mainstay in other industries for years, is now becoming more prevalent in healthcare, but still lags behind the digital marketing strategies and uses of tools like other industries. A well executed marketing plan will also assure your clients that it is their well being that give the utmost priority. Healthcare marketing is not just about health but also your reputation and goodwill which cannot be built overnight and needs a lot of patience. There are a lot of tangible, intangible benefits which a patient gets

™

| March 2018 |

from a professional and these plans are what will actually help you retain your clients. So everyone needs an eective and strategic digital marketing plan which should helps patients know the perks of being associated with your brand. This will help you to nurture your healthy relationship with your stakeholders-existing and new.

About the Author: Sudip Das has set an example for being a successful digital marketer, being consistent with his efforts and able to connect with the users. It was in 2013, when he comes up with his own startup name Wikreate Communication, under which he develops different business model related to health, media and visual marketing.

Sudip Das Founder of Wikreate

™

| March 2018 |

10 33

Social Media Marketing FOR

PHARMA INDUSTRY

T

“

he absence of pharma brands on social media creates a significant void of reputable healthcare information to aid patients,” writes Dawn Lacallade, LiveWorld’s Chief Social Strategist.

Social media infiltrate virtually every facet of an individual's digital life. Today, patients are using social media as a major source of information and healthcare research. Thus, it is essential that pharma companies should be present on social media to provide full and accurate information to the consumers. To comprehend how social media can assist patients, it is crucial to understand what compels people to use social media as a source of information.

Social media allows interaction among people which involves exchange and creation of information. It is the perfect conduit for pharmaceutical companies to connect with their customers, patients and physicians.

According to the current FDA regulations, pharma companies are not able to easily join in a conversation to provide accurate and balanced information. Regulations dictate that, in a single social post, brands are required to provide precise facts on the benefits and hazards associated with conditions and products. Due to the character limitations on many social media platforms, most pharma companies prefer to stay out of the conversation. This

10 34

results in circulation of falsified information. This information can be either marginally inaccurate or significantly harmful.

Although the communication of pharmaceutical industries is highly regulated, they are gradually adopting social media platforms to reach and interact with consumers and healthcare professionals. Here are some of the top social media practices to look out for: Crafting Customer Experience Several marketers think that their job is finished once the sales team takes over, but in reality, it is just the beginning.

The way people experience your brand will impact the way they think about you, which will have an enormous effect on the success of your company in the long run. Devoting a part of the marketing budget to nurture the existing clientele will make their experience splendid and thus promote brand loyalty. It is also crucial to respond whenever your brand in mentioned publicly, whether positively or negatively, which will help cultivate a strong and lasting relationship with your customers. Younger generations are increasingly withdrawing from traditional social media platforms and adopting more innovative channels that are more intimate in the way of communication. To keep up with this challenge, companies need to find a way to automate the process wherever possible.

™

| March 2018 |

Pharmaceutical Marketing Regulating Content Pharma companies need to develop content marketing strategies that merge each piece of content on every channel with their organization’s objectives and customers’ needs.

Creators need to have a clear business objective including the value that will be delivered to distinct audiences. All companies need to have a social media compliance officer who will work closely with a corporate legal counsel and develop a complete strategy and decide if there will be consolidated social media posting or if individual employees will have the consent to participate. And lastly, it is critical that all employees understand their role in corporate social media and be trained on the rules.

Overall Integration Pharma companies should stop thinking about content marketing and social media as add-ons. To boost their outcome for clients, content and social marketing need to be a part of almost every program. To develop a fully integrated program, companies need to involve influencers and content marketers during the initial stages.

Implementing an organized approach to content and moderation will not only optimize the processes, but also aid in assuring authorities that all the bases are covered to protect and provide value for the brand.

directly affected by a disease or are being treated with a specific product, while others have gained a lot of knowledge about a condition and are considered as Subject Matter Experts. The common trend is to select someone who has an ever-increasing community of followers who value their opinion.

Numerous companies still think of social media as merely a marketing tool which is not true anymore. Consumers learn about products on different social networks and seek customer service on messaging channels. Moreover, good storytelling has always been an essential part of effective marketing. But social media is changing the way audiences consume stories and pharma companies will be required to keep up with the evolution of social storytelling if they want to remain relevant.

Yet there is still a note of caution with compliance being the foremost priority of pharmaceutical companies. But as industries are starting to adopt social media without clear regulatory guidance, remaining compliant will be the main challenge to face.

Investing in Employees An independent survey discovered that 72% of social media users expect response within an hour from the brands they follow. This has caused brands to start heavily investing in cross-functional social media teams that can keep up with the increasing number of client pings every day.

Encouraging and incentivizing team members to share brand messages on their own social media accounts, is predicted to be a game-changer in the coming days.

However this cannot be forced, it is essential for employees to want to share company posts, and along with this the content has to resonate with their own audiences.

Influencer Marketing Influencer marketing will continue to develop and become an even more established part of the strategy.

Currently many brands try influencer marketing and fail as it is not easy to find effective influencers. Additional data will help in selection of the right influencers and analyze the results from influencer campaigns. Today, in healthcare, influencers are often regular people. Some are

™

| March 2018 |

10 35

The Much Needed Industry,

Home Healthcare Industry

I

ndia has been a witness to magnificent reforms especially in the healthcare sector. Known as the sunshine segment in the arcade, it is one of the major players that drive employment and the process of revenue generation in India. Novelty and advancement in any fragment is generally for: ● ●

Cost reduction Fulfilling the need of the hour

With outlays touching sky high, lack of pertinent in-hospital mandates and nonexistent comfort, Indian healthcare industry demanded a renaissance desperately. The startups began to put their utmost dedication and creative minds to work in a way that the country embraced modern technological improvements in a way to benefit the masses.

This led to the pioneer of home health care services and was embraced with open arms worldwide. Commencement of this upheaval evacuated the crisis that otherwise lingered around. From having no proper facilities to treat even the basic medical conditions, India is now one of the largest platforms serving to customer-eccentric home health care services.

One such salient contributor to the health and welfare diligence is Healers at Home. The birth of Healers at Home was on a practical foundation.

During my corporate days, the back pain had sucked my exuberance and hassling for appointments with physiotherapists and orthopedics added to the agony. A vague thought plagued through my head: What if there was an aid that could reach out to me at my expediency and accessibility rather than otherwise? The best and the right outcome of any unusual thing bears fruit only when it is tried and tested and that’s how the idea of Healers at Home came around. The pilot project for Healers at Home started on 21st June, 2014 and my dedicated team is still striving hard to fit the bills of countless individuals.

Well, doing justice to the emerging trends is not a piece of cake. Catering to home health care services does bring a chain of crisis making it difficult for to meet the rising

10 38

demands with quality and qualified workforce. Being a staunch follower of the rule that the best is yet to come, my panel prevalently works in and out to sustain the ever-growing requisites with unswerving and budding talent. The workforce is picked from A-grade and premium colleges who are certified, trained and experienced in their niche of obligation thus allowing more than 200000 verified customers till date to trust us and our set of knacks. Another conundrum that health care industry is stuck with is the demographics of the country. The urban area is accessible both remotely and otherwise but when it comes to rural areas, medical backing is a challenge. Trying to build a medically inclusive country, we are delivering Physiotherapy, Yoga, Mother and Child Care, Corporate yoga, Nursing care, Attendant Care and Elder Care in at home and offices for areas in and around Delhi, Noida, Greater Noida, Faridabad, Ghaziabad, and Gurugram.

Healers at Home was launched with a basic motive; true healing and happiness without having to make efforts for it.

We live in a digitally advanced nation and handiness demands to be the modern necessity. I mean just give it a levelheaded thought, who would prefer moving about on days when you really want to get comfy under your favorite sheets? The answer to any possible question that involves healthcare is always preferred at home.

Home healthcare industry is an impeccable combination of expediency and technological encroachment. It is now possible to avail tedious medical procedures like vaccinations, dialysis, urinary catheterization and even post medical care at half the cost and double the convenience as compared to the hospital. My ultimate goal vests in letting the patient be the ultimate decider of his comfort without hampering his time, routine and the life of any person related to them. Though difficult, this home based healthcare setup will be a game changer in the near future is what I have faith in! I do not want to just fulfill the medical aspect with our home health care services but both my team and I are striving to merge innovation, technology, and customer satisfaction is a way that home health care outcomes are enormous to benefit every individual in indigence. ™

| March 2018 |

Expert’s Advice

Kshitij Garg Founder

bout

Author

Kshitij Garg is Founder at Healers at Home. Kshitij has done his bachelors from IIT Kanpur. Post that, he was awarded the Young India Fellowship by Ashoka University in collaboration with University of Pennsylvania.

He has more than 5 years of experience during which he ran 3 startups and did Product Management at 9.9 Media. At 9.9 Media, he led various products like Digit.in (India’s one of the most visited tech website). He has also worked with the Office of Member of Parliament - Mr. Naveen Jindal in the past.

He envisions Healers at Home providing home heathcare services and wellness services to everyone around the world in a single click. The Healers at Home Core Team comprises of IIT Kanpur graduates and Healthcare Professionals who have a diverse combined experience of over 35 years in the field of Healthcare, Marketing, Microfinance and Technology.

They currently provide 5 services at home: Physiotherapy, Yoga, Nursing, Attendant Care and Mother & Child Care. Their investors include industry pioneers like: 1) Mr. Daljit Singh President, Fortis Healthcare 2) Mr. BVR Mohan Reddy - Padam Shri Awardee 3) Dr. Pramath Raj Sinha - Founder, ISB & Ashoka University.

Kshitij practices Yoga & Meditation on a daily basis and implements his learnings from Yoga to Healers at Home. The learnings and team efforts have helped the startup grow 10X in terms of traction and revenue in the year 2016 and they have done more than 200,000 Home Visits so far.

™

| March 2018 |

10 39

Trends in Pharma Industry

Revolutionary

Factors

Affecting

Pharmaceutical Industry

T

he world is changing at an ever-increasing pace.

Shopping malls have been replaced with online shopping; traditional classrooms have given way to online classes and soon, driving your own car may seem like a nostalgic activity. Pharmaceutical Industry is no different. Pharmaceutical and life sciences companies are facing an upsurge of challenges as a part of what could be the New Health Economy.

The global pharmaceutical industry is said to have a relative growth over the next few years. Be on guard for the following pharmaceutical trends and set the right course for your strategies.

Patient Empowerment Gone are the days when individuals relied on doctors for diagnosis. Due to the easily accessible information, patients today can learn about their health conditions online and obtain the necessary knowledge to be aware of the available treatments and choose the ones they prefer. Doctors have lost their power to influence this choice and thus pharma companies have to look for new and innovative ways to get their medications sold.

The patient-first business model helps to do just that. The pharma companies which succeed in patient engagement increases their chances of commercial and regulatory success as decisions are taken in accordance with the patient's needs and results. For productive collaboration with patients, pharma companies are required to find better communication techniques and also invest in more effective data analytics. Although many patients are skeptical about sharing their personal information, an independent survey found that most people are willing to let pharma companies know about their medical activities if it leads to a better care.

Furthermore, Virtual reality is used to motivate consumers

10 40

to be more active and compassionate. If used as a marketing tool, this can build empathy, enable training on medical devices and create detailed demos that illustrate the mechanism of action with extreme clarity and help facilitate a stronger bond between pharma companies and consumers.

Increase in Biosimilars Biosimilar products are suspected to continue to have a significant impact on the pharmaceutical industry. Due to the increase in approval of biosimilars and their rapid introduction in the market, market conditions will have to evolve accordingly. This will not only provide patients with numerous treatment options but also have the ability to get drugs for serious disorders at a much cheaper cost than the original biologics. This is an opportunity for manufacturers specializing in generics and biosimilars to grow their business rapidly. It is said to be a very sizeable opportunity and if companies do it correctly, the probability of success is higher than the traditional pharmaceutical approach and the cost of development should be lower than novel drugs.

Precision Medication Arbitrary costs of trial-and-error therapies and the increasing need for decreasing the cost of healthcare has inspired the transition of one-fits-all model to the outcomebased targeted therapies. Precision medicine eliminates the need for guesswork, variable diagnosis, and generalized treatment strategies. Thus far only a few cases exists which used genetic information to make a decision regarding a suitable treatment.

Currently, the drug development industry is heavily investing in precision medicine. Furthermore, scientific advancements in genomics field suggest that time and costs are no longer a hindrance for precision medicine. Increasing awareness about the human genome and its correlation with disease progression are expected to shift the current focus beyond oncology.

™

| March 2018 |

3D Printed Drugs 3D printing assures a future of drugs printed on demand with custom doses and the possibility that price may no longer be an obstacle. The first 3D printed medicine that dissolves rapidly is used for the treatment of epilepsy. Small companies are deriving other solutions for creating drugs that can be metabolized faster and can be marketed more easily. Because of this entire pharma industry will have to be restructured within years, perhaps even months.

Digital Healthcare The global healthcare industry has seen a transformation which has been driven by advances in biopharmaceutical, medical and surgical procedures and automation. The Digital Health applications in information and communication technologies aid to utilize the full potential of big data analytics and change the healthcare industry. Today, if the pharma companies are not thinking about how to integrate such programs and educational resources and not just use them as a tool to promote, they will be left behind.

The digitization of the patient, from the electronic health records to genome mapping allows for targeted treatment that is revolutionizing healthcare. The introduction of mobile health sensors and wearables offers a real-time insight into a patient’s progress. Furthermore, computers with the ability to easily analyze enormous amounts of data and scientific literature can assist pharma companies in the development of new drugs and improve the existing ones.

Counterfeit Drugs Counterfeit Drugs are fake medicine. They can be either contaminated or contain the wrong or lack of active compound. Pharma companies are required to track the product ID from manufacturing process and trace its movement throughout the supply chain. These drugs are not just available via the black market, but are also accessible through legitimate pharmacies. Fake drugs are said to be more deadly than terrorism. An independent survey concluded that 200,000 people are killed on an average due to counterfeit drugs.

All of this concludes into the complexity of the supply chain of pharmaceuticals. With an increased dependence on outsourced manufacturers and third party logistics, the lack of clarity across the various components of the supply chain has never been so blurred. This together with the intrinsic demand unpredictability from anywhere in the world and the disparity of supply and demand makes an increasingly volatile value chain.

™

| March 2018 |

10 41

10ADMIRED T H E

MOST

PHARMA companies in 2018

GLOBAL CALCIUM Making Everyday Life Better

W

ith more people around the world dying from obesity than starvation, poor nutrition is now recognized as a major risk factor for chronic diseases. Also an ageing population gives rise to lifestyle-related diseases, whose impact can be lessened by making healthier choices earlier in life.

Given the deteriorating health condition of the society, patients are being encouraged to take part in their own treatment. At the front lines of this battle are nutritional products that have been proven to help prevent or cure diseases. These nutritional products present a tantalizing opportunity for breakthroughs to prevent and manage common health problems, offering consumer-focused solutions to issues that are currently addressed only by pharmaceutical interventions.

The company initially commenced operations with a technology joint venture with Sandoz, Switzerland and is now family owned and has active operations in over 60 countries. By volume, it is ranked as one of the top three producers in the world of organic mineral products, with a focus on advanced Injectable Active Ingredients (IAI).

The company has been successfully inspected by several global drug authorities, including USFDA, EUGMP, COFEPRIS, KFDA, etc.

An Expert Mentor Global Calcium is backed by an excellent management team comprising of industry specialists, technocrats, entrepreneurs and business specialists bringing in strong domain expertise in fields such as investment banking, to consulting, to behind the scenes pure sciences.

Despite being a hot spot for growth, pharmaceutical industry still suffers from the same challenges as the rest of the sector, with market growth barely keeping up with the rise in the gross domestic product.

Apprehending this, Arif Vazirally founded Global Calcium in 1979 - one of the world’s most innovative companies in Carbohydrate Chemistry with 9 manufacturing plants spread across 3 campuses in Southern India.

Arif Vazirally is the Chairman of the Calcium Group, which includes Global Calcium. His grandfather, started one of the first large scale glass factories in India in the early part of the 20th century, namely, Vazir Glass Works.

One of their key customers was Sandoz and what started as a simple conversation progressed to a comprehensive business opportunity. Even today, with over 1200 customers across the globe, Sandoz, which is a part of the Novartis Group, remains one of Global Calcium’s oldest and key customers.

Today, Global Calcium, which invested in its own windmills over a decade ago, is a gold-standard holder in green energy by the UNFCC. It is an EUGMP/USFDA/Japan FDA certified global company and an established authority for global pharmaceutical standards.

Today the company is managed by its CEO, Sahil Vaz and in 2010; Global Calcium became the first company in the world to synthesize a double-mineral-double acid salt called ‘Magical’ for which it received numerous awards, patents and recognition amongst global experts in the field.

10 42

™

| March 2018 |

‘‘

‘‘

Our vision is to continue to focus on niche products for critical pharmaceutical and biological applications with comprehensive traceability and a superb global distribution network

In 2018, the company expects to be the first company in the world to receive a patent on unique lifesaving drugs for iron injection. With a full time work force exceeding 1000 people, Global Calcium has over 150 specialized scientist and chemists.

Characteristic Services and Strategies Given that India is just one position behind the largest pharmaceutical industry in the world, Global Calcium is posed to deliver premium healthcare products using the best of business excellence.

Global Calcium currently has 9 manufacturing plants with a portfolio of over 100 active pharmaceutical products. Their vision is to continue to focus on innovative niche products for critical pharmaceutical and biological applications with comprehensive traceability and a superb global distribution network. Furthermore, as part of the ‘Made-In-India’ initiative, the company is investing heavily in down-stream manufacturing of its key products. The company spends more than 20% of its annual profits in R&D and regulatory activities. In the last 2 years, the company has ploughed back more than

™

| March 2018 |

Sahil Vaz CEO

65 crores in product innovation and process optimization.

Global Calcium prioritizes Research and Development over everything else; companies today are well aware that only with superior R&D can they continue to innovate and deliver international-quality products. A team of focused high-end specialists uses optimized processes to test, pilot trial, and retest every product innovation. The focused R&D effort and initiatives are behind the cost advantages that ensures competitiveness despite using advanced machinery with minimum manual intervention.

Future Roadmap Even though the company is approaching 4 decades, the culture and vibe in the company is that of a start-up. This is despite the fact, that even today, several of the founding employees are still engaged in active roles across the organization. This is partially achieved by having an ultra-flat hierarchy and a highly meritorious approach to roles and responsibilities.

43 01

Ad10